Funds and ETFs Microbot Medical Inc.

Equities

MBOT

US59503A2042

Biotechnology & Medical Research

Market Closed - Nasdaq 04:30:00 2024-04-26 pm EDT 5-day change 1st Jan Change
0.88 USD +1.95% Intraday chart for Microbot Medical Inc. +1.73% -46.34%
Microbot Medical Inc. is a pre-clinical medical device company. The Company is specializing in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is primarily focused on leveraging its robotic technologies with surgical robotics to improve surgical outcomes for patients. Its technological platforms include LIBERTY and NovaCross. Using its LIBERTY Endovascular Robotic Surgical System, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. LIBERTY Endovascular Robotic Surgical System addresses the needs of interventional cardiology, interventional radiology and interventional neuroradiology markets.
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.88 USD
Average target price
7 USD
Spread / Average Target
+695.45%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. MBOT Stock
  4. Funds and ETFs Microbot Medical Inc.